Traumatic Brain Injury News and Research

RSS
Traumatic brain injury (TBI), a form of acquired brain injury, occurs when a sudden trauma causes damage to the brain. TBI can result when the head suddenly and violently hits an object, or when an object pierces the skull and enters brain tissue. Symptoms of a TBI can be mild, moderate, or severe, depending on the extent of the damage to the brain. A person with a mild TBI may remain conscious or may experience a loss of consciousness for a few seconds or minutes. Other symptoms of mild TBI include headache, confusion, lightheadedness, dizziness, blurred vision or tired eyes, ringing in the ears, bad taste in the mouth, fatigue or lethargy, a change in sleep patterns, behavioral or mood changes, and trouble with memory, concentration, attention, or thinking. A person with a moderate or severe TBI may show these same symptoms, but may also have a headache that gets worse or does not go away, repeated vomiting or nausea, convulsions or seizures, an inability to awaken from sleep, dilation of one or both pupils of the eyes, slurred speech, weakness or numbness in the extremities, loss of coordination, and increased confusion, restlessness, or agitation.
RegeneRx common stock to be quoted on OTC Bulletin Board following NYSE Amex suspension

RegeneRx common stock to be quoted on OTC Bulletin Board following NYSE Amex suspension

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

Enrollment begins in Phase 2 trial of RegeneRx’s RGN-259 in dry eye associated with graft vs. host disease

Enrollment begins in Phase 2 trial of RegeneRx’s RGN-259 in dry eye associated with graft vs. host disease

Researchers receive $100,000 NFL grant to study tissue engineering for spinal injuries

Researchers receive $100,000 NFL grant to study tissue engineering for spinal injuries

FDA approves Neuralstem's IND to initiate NSI-189 Phase Ia safety trial in major depression

FDA approves Neuralstem's IND to initiate NSI-189 Phase Ia safety trial in major depression

Web-based screening tools for determining TBI or PTS among military service members

Web-based screening tools for determining TBI or PTS among military service members

Oxygen Biotherapeutics and SMP sign Binding Letter of Intent for joint chronic ischemic wound research

Oxygen Biotherapeutics and SMP sign Binding Letter of Intent for joint chronic ischemic wound research

Synthetic derivative of curry spice can be effective neuroprotective for stroke and TBI

Synthetic derivative of curry spice can be effective neuroprotective for stroke and TBI

Marin announces new joint venture with Mt. Tam Spine Center and UCSF Neurosurgery

Marin announces new joint venture with Mt. Tam Spine Center and UCSF Neurosurgery

Oxygen Biotherapeutics reports net revenue of $27,126 for second quarter of fiscal 2011

Oxygen Biotherapeutics reports net revenue of $27,126 for second quarter of fiscal 2011

Novel drug therapy treats brain diseases

Novel drug therapy treats brain diseases

Incidence of EPTS in children with TBI more than twice the rate in adults: Study

Incidence of EPTS in children with TBI more than twice the rate in adults: Study

MRI scans quantifies disruptions in blood brain barrier, identifies TBI patients at risk of developing PTE

MRI scans quantifies disruptions in blood brain barrier, identifies TBI patients at risk of developing PTE

AANS injury prevention tips during winter holiday season

AANS injury prevention tips during winter holiday season

Study reveals higher mortality rate among veteran status epilepticus patients

Study reveals higher mortality rate among veteran status epilepticus patients

AES annual meeting features special session on implications of combat-induced traumatic brain injury

AES annual meeting features special session on implications of combat-induced traumatic brain injury

RegeneRx receives patent for Tβ4 to prevent immunological responses from toxic agents

RegeneRx receives patent for Tβ4 to prevent immunological responses from toxic agents

Clinicians should assess sleep-wake disturbances to understand physiology of Parkinson's disease

Clinicians should assess sleep-wake disturbances to understand physiology of Parkinson's disease

Scientists identify signaling pathway and receptor for thymosin beta 4

Scientists identify signaling pathway and receptor for thymosin beta 4

Experts formulate research related to psychological adjustment and traumatic brain injury

Experts formulate research related to psychological adjustment and traumatic brain injury

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.